Iraqi Kurdish soldiers and Syrian rebels join the battle against ISIS in Kobani, the search continues for missing students in Mexico, and the last U-S Marines pull out of a key base in Afghanistan: Please join us to discuss this week's top international stories
An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.
- Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
- Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
Most Recent Shows
Last-minute campaigning with just days to go before the midterm elections. The Federal Reserve ends its bond-buying program. And debate continues over Ebola quarantines in the U-S. A panel of journalists joins Diane for a conversation about the week's top stories.
According to a recent UN panel, the build-up of garbage in the world’s oceans could cause more than $13 billion in damage to marine life and habitats. A look at the causes and possible remedies for the flow of trash into the world's oceans.